These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 23267520)
1. The usefulness of gadolinium-enhanced images on a follow-up magnetic resonance image in suspected multiple sclerosis. Moore FG; Levental M Can Assoc Radiol J; 2013 Nov; 64(4):358-62. PubMed ID: 23267520 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Unenhanced and Gadolinium-Enhanced Imaging in Multiple Sclerosis: Is Contrast Needed for Routine Follow-Up MRI? Sadigh G; Saindane AM; Waldman AD; Lava NS; Hu R AJNR Am J Neuroradiol; 2019 Sep; 40(9):1476-1480. PubMed ID: 31439627 [TBL] [Abstract][Full Text] [Related]
3. The role of contrast-enhanced and non-contrast-enhanced MRI in the follow-up of multiple sclerosis. Zarei F; Ghaedian M; Ghaedian T Acta Radiol; 2021 Jul; 62(7):916-921. PubMed ID: 32762243 [TBL] [Abstract][Full Text] [Related]
7. [The characteristics of enhanced gadolinium DTPA brain magnetic resonance images in 298 multiple sclerosis patients]. Zhang H; Xu XH; Zhao ZG; Guo H; Qiao LY; Yin J; Hou SF; Wei XF; Wen SG; Geng Y; Jiao YJ; Liu JH; Wang H Zhonghua Nei Ke Za Zhi; 2003 Jul; 42(7):490-1. PubMed ID: 12921611 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Silver NC; Good CD; Barker GJ; MacManus DG; Thompson AJ; Moseley IF; McDonald WI; Miller DH Brain; 1997 Jul; 120 ( Pt 7)():1149-61. PubMed ID: 9236628 [TBL] [Abstract][Full Text] [Related]
9. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P; Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085 [TBL] [Abstract][Full Text] [Related]
10. Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. Lebrun C; Bensa C; Debouverie M; De Seze J; Wiertlievski S; Brochet B; Clavelou P; Brassat D; Labauge P; Roullet E; J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):195-8. PubMed ID: 18202208 [TBL] [Abstract][Full Text] [Related]
11. The role of MRI in the diagnosis of multiple sclerosis. Traboulsee AL; Li DK Adv Neurol; 2006; 98():125-46. PubMed ID: 16400831 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery and delayed contrast-enhanced brain MRI in multiple sclerosis. Bagheri MH; Meshksar A; Nabavizadeh SA; Borhani-Haghighi A; Ashjazadeh N; Nikseresht AR Acad Radiol; 2008 Jan; 15(1):15-23. PubMed ID: 18078903 [TBL] [Abstract][Full Text] [Related]
13. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA. Paolillo A; Piattella MC; Pantano P; Di Legge S; Caramia F; Russo P; Lenzi GL; Pozzilli C J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288 [TBL] [Abstract][Full Text] [Related]
14. Serial gadolinium-enhanced magnetic resonance imaging in patients with multiple sclerosis treated with mitoxantrone. Krapf H; Mauch E; Fetzer U; Laufen H; Kornhuber HH Neuroradiology; 1995 Feb; 37(2):113-9. PubMed ID: 7760994 [TBL] [Abstract][Full Text] [Related]
15. Is gadolinium necessary for MRI follow-up evaluation of cystic lesions in the pancreas? Preliminary results. Macari M; Lee T; Kim S; Jacobs S; Megibow AJ; Hajdu C; Babb J AJR Am J Roentgenol; 2009 Jan; 192(1):159-64. PubMed ID: 19098196 [TBL] [Abstract][Full Text] [Related]
16. Limited Utility of Gadolinium Contrast Administration in Routine Multiple Sclerosis Surveillance. Johnston G; Johnson T; Solomon AJ; Bazylewicz M; Allison JB; Azalone E; Ulano A J Neuroimaging; 2021 Jan; 31(1):103-107. PubMed ID: 33146941 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Kermode AG; Tofts PS; Thompson AJ; MacManus DG; Rudge P; Kendall BE; Kingsley DP; Moseley IF; du Boulay EP; McDonald WI Neurology; 1990 Feb; 40(2):229-35. PubMed ID: 2300240 [TBL] [Abstract][Full Text] [Related]
19. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions. Uysal E; Erturk SM; Yildirim H; Seleker F; Basak M AJR Am J Roentgenol; 2007 Mar; 188(3):697-702. PubMed ID: 17312056 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis. Hsueh CJ; Kao HW; Chen SY; Lo CP; Hsu CC; Liu DW; Hsu WL J Neurol Sci; 2013 Jun; 329(1-2):51-4. PubMed ID: 23597668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]